Research Article
Outcomes of Patients with Malignancy Admitted to the Intensive Care Units: A Prospective Study
Table 1
Patient characteristics and ICU stay.
| | Patient characteristics |
| | Number of patients, N | 272 |
| | Age, yr. | | Mean | 64.25 |
| | Type of malignancy, n (%) | | Lung cancer | 46 (16.9%) | | Leukemia | 42 (15.4%) | | Lymphoma | 37 (13.6%) | | Others | 147 (54.1%) |
| | Stage, n (%) | | Solid and hematologic tumors other than leukemia | | Low-intermediate (stages I–III) | 49 (22.8%) | | High (stage IV) | 166 (77.2%) | | Leukemia | | Low or intermediate risk | 12 (30.8%) | | High risk | 27 (69.2%) |
| | Malignancy status, n (%) | | Controlled | 198 (73.9%) | | Uncontrolled | 70 (26.1%) |
| | Aim of treatment, n (%) | | Curative | 160 (60.6%) | | Palliative | 104 (39.4%) |
| | Reason for ICU admission, n (%) | | Sepsis | 147 (54%) | | Respiratory failure | 90 (33.1%) | | Altered general status | 20 (74%) | | Hemorrhagic shock | 15 (5.5%) |
| | Mode of admission, n (%) | | Through ED | 180 (66.2%) | | Transfer from floor | 92 (33.8%) |
| | Laboratory values, n (%) | | Anemia | 226 (83.1%) | | Leukopenia | 58 (21.3%) | | Thrombocytopenia | 107 (39.3%) | | Renal impairment | 103 (38.1%) |
| | ICU complications, n (%) | | Sepsis | 226 (83.1%) | | Invasive fungal infection | 20 (7.4%) | | ARDS | 63 (23.2%) | | AKI | 152 (55.9%) | | MOF | 94 (34.7%) |
| | ICU care, n (%) | | Mechanical ventilation | 157 (57.7%) | | Vasopressor use | 185 (68%) | | Antibiotic use | 266 (97.8%) | | Dialysis | 45 (16.5%) |
| | ICU length of stay, day | | Mean | 14 | | Median (range) | 7 (1–153) |
|
|
According to Rai classification. |
